Rating Rationale
August 04, 2020 | Mumbai
Temple Packaging Private Limited
Long-term rating downgraded to 'CRISIL BB+/Stable'; short-term rating withdrawn
 
Rating Action
Total Bank Loan Facilities Rated Rs.13 Crore (Reduced from Rs.150 Crore)
Long Term Rating CRISIL BB+/Stable (Downgraded from 'CRISIL BBB-/Negative')
Short Term Rating CRISIL A3 (Withdrawn)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has downgraded its rating on the long-term bank facilities of Temple Packaging Private Limited (TPPL) to 'CRISIL BB+/Stable' from 'CRISIL BBB-/Negative'. CRISIL has also withdrawn its rating on bank loan facilities worth Rs 137 crore on the company's request. The withdrawal is in line with CRISIL's policy on withdrawal of bank loan ratings.
 
The downgrade reflects deterioration in TPPL's liquidity with delay in commencement of operations of new unit, stretched working capital and impact on operations amid the Covid-19 pandemic This has led to high reliance on short term borrowings and reduced cushion available to repay its term debt obligations. Net cash accruals are expected to be around Rs. 28-30 crores in fiscal 2021, against high repayment obligations of Rs. 24 crores. The bank limit remained 93% utilised over the past 7 months ended June 2020.
 
The ratings continue to reflect the extensive experience of promoters and established relationship with reputed clientele and above-average financial risk profile. These strengths are partially offset by volatility in raw material prices, large working capital requirements and continuous investment in capacity expansion.

Key Rating Drivers & Detailed Description
Strengths:
* Extensive experience of the promoters and established relationship with reputed clientele: The promoters have an experience of over two decades in the printing and packaging industry, especially in the niche business of manufacturing precision folded inserts and outserts. They have established strong relationship with leading pharmaceutical customers such as Dr Reddy's Laboratories Ltd, Ranbaxy Laboratories Ltd, Aurobindo Pharma Ltd, Glenmark Pharmaceuticals Ltd, and Lupin Ltd among others. Repeat orders from customers have led to increase in revenues to Rs. 256.5 crores in fiscal 2020, from Rs. 205 crores in fiscal 2016.
 
* Above-average financial risk profile: The capital structure has been robust in the past although it has moderated in past three years due to capex incurred. Gearing and total outside liabilities to adjusted networth were 0.97 times and 1.24 times, respectively, as on March 31, 2020, due to strong networth of Rs. 148 crores. This coupled with the healthy operating margin has resulted in comfortable debt protection metrics as reflected in net cash accrual to total debt and debt coverage ratios of 0.23 and 4.98 times, respectively, in fiscal 2020. Financial risk profile is estimated to remain at comfortable levels in absence of any further debt funded capex.
 
Weakness:
* Susceptibility of operating margin to raw material price fluctuations:  The operating margin, though healthy, has remained susceptible to raw material price fluctuations. TPPL's low bargaining power with customers limits its ability to pass on any sudden increase in raw material prices to them. Besides, with the increasing competition leads to increased pricing pressure and may affect the profitability over the medium term.
 
* Working capital-intensive operations: Gross current assets (GCAs) of around 138 days as on March 31, 2020, largely driven by debtors of 90 days with moderate inventory, reflects working capital intensive operations. TPPL offers a credit of 90-120 days to its customers which sometimes extends payment. Steady increase in incremental working capital requirements has led to increasing reliance on its cash credit limit.
 
* Continuous investment in capacity expansion: Return on Capital Employed (RoCE) was modest at 10.5% in fiscal 2020 on account of continuous capex and limited growth in scale of operations. Operations are highly capital intensive and to TPPL has to continuously invest in fixed assets. The benefits from the incremental investments in the fixed assets accrue only after the initial stabilisation period of around three years, which has thereby resulted in no significant improvement in scale, despite continuous capex.
Liquidity Stretched

TPPL has stretched liquidity with expected cash accruals of around Rs. 28-30 crore per annum in fiscal 2021 and fiscal 2022, tightly matched against repayment obligations of Rs. 24 crores annually. Cash and cash equivalents were Rs. 2.8 crore as on March 31, 2020. Fund based limits of Rs. 47 crore is 93% utilized on an average over the 7 months ended June 2020. CRISIL expects internal accruals, cash & cash equivalents and unutilized bank lines to be sufficient to meet its repayment obligations as well as incremental working capital requirements.

Outlook: Stable

CRISIL believes TPPL's operating efficiency will remain constrained over the medium term due to decline in profitability and large capex requirement, constraining RoCE
 
Rating Sensitivity factors
Upward factors

* Sustained growth in revenues and improvement in operating profitability, leading to higher cash accruals above Rs. 40 crores
* Decrease in bank limit utilisation below 85%, leading to better financial profile and liquidity
 
Downward factors
* Debt-funded capital structure or stretch in working capital cycle, leading to significant deterioration in financial risk profile
* Substantial decline in revenue or profitability impacting net cash accruals (below Rs. 28 crores) and cushion for debt repayment

About the Company

Incorporated in 1994 in Mumbai, TPPL manufactures printed precision folded package inserts, outserts, and cartons mainly for the pharmaceutical industry. The manufacturing units are in Daman (Daman and Diu), Baddi (Himachal Pradesh), and Hyderabad (Telangana); its registered office is in Mumbai. TPPL is currently setting up another facility in Pithampur, Indore which is expected to commence operations in fiscal 2020. It is promoted by Mr. Vimal Joshi and his brother Mr. Pranav Joshi.

Key Financial Indicators
Particulars Unit 2020* 2019
Revenue Rs crore 256.5 245.5
Profit after tax (PAT) Rs crore 15.3 6.4
PAT margin % 6.0 2.6
Adjusted debt/adjusted networth Times 0.97 1.09
Interest coverage Times 4.98 3.95
*Provisional

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of instrument Date of allotment Coupon rate (%) Maturity date Issue size
(Rs crore)
Complexity levels Rating assigned
with outlook
NA External Commercial Borrowings NA NA March 2023 13.0 NA CRISIL BB+/Stable
NA Cash Credit NA NA NA 21 NA Withdrawn
NA Long Term Loan NA NA March 2024 10.0 NA Withdrawn
NA Term Loan NA NA March 2024 20.0 NA Withdrawn
NA Term Loan NA NA September 2020 1.29 NA Withdrawn
NA Term Loan NA NA September 2020 0.90 NA Withdrawn
NA Term Loan NA NA March 2025 5.00 NA Withdrawn
NA Term Loan NA NA March 2021 5.24 NA Withdrawn
NA Corporate Loan NA NA March 2022 11.83 NA Withdrawn
NA Term Loan NA NA March 2023 16.5 NA Withdrawn
NA Term Loan NA NA March 2025 9.24 NA Withdrawn
NA Short Term Loan NA NA NA 5.0 NA Withdrawn
NA Bill Discounting NA NA NA 26.0 NA Withdrawn
NA Bank Guarantee NA NA NA 2.0 NA Withdrawn
NA Letter of Credit NA NA NA 3.0 NA Withdrawn
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  13.00  CRISIL BB+/Stable  05-02-20  CRISIL BBB-/Negative/ CRISIL A3  19-03-19  CRISIL BBB/Stable  23-04-18  CRISIL BBB+/Negative  12-05-17  CRISIL BBB+/Negative  CRISIL BBB+/Negative 
            06-03-19  CRISIL BBB/Stable           
Non Fund-based Bank Facilities  LT/ST  5.00  Withdrawn 05-02-20  CRISIL A3  19-03-19  CRISIL A3+  23-04-18  CRISIL A2  12-05-17  CRISIL A2  CRISIL A2 
            06-03-19  CRISIL A3+           
All amounts are in Rs.Cr.
 
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Bank Guarantee 2 Withdrawn Bank Guarantee 2 CRISIL A3
Bill Discounting 26 Withdrawn Bill Discounting 26 CRISIL BBB-/Negative
Cash Credit 21 Withdrawn Cash Credit 21 CRISIL BBB-/Negative
Corporate Loan 11.83 Withdrawn Corporate Loan 11.83 CRISIL BBB-/Negative
External Commercial Borrowings 13 CRISIL BB+/Stable External Commercial Borrowings 13 CRISIL BBB-/Negative
Letter of Credit 3 Withdrawn Letter of Credit 3 CRISIL A3
Long Term Loan 10 Withdrawn Long Term Loan 10 CRISIL BBB-/Negative
Short Term Loan 5 Withdrawn Short Term Loan 5 CRISIL A3
Term Loan 58.17 Withdrawn Term Loan 58.17 CRISIL BBB-/Negative
Total 150 -- Total 150 --
Links to related criteria
Assessing Information Adequacy Risk
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings
The Rating Process
Understanding CRISILs Ratings and Rating Scales

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Rahul Guha
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Ankita Gupta
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8104
ankita.gupta@crisil.com


Prayag Sinha
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 4101
Prayag.Sinha@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL